Nephrosis, Lipoid: all 75 studies

Page 1 of 1. Open to participants first (32), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Effectiveness and Safety of Sibeprenlimab in Participants With Primary Membranous Nephropathy, Immune-mediated Focal Segmental Glomerulosclerosis, and Minimal Change DiseaseNot yet recruitingNCT07861113Phase 2
• A Trial to Assess the Efficacy and Safety of Obinutuzumab in Treating Adults With Minimal Change Disease (MCD)RecruitingNCT07710157Phase 2
• Comparison of Efficacy and Safety of Albumin Versus Fresh Frozen Plasma in Managing Diuretic Resistant Edema in Children With Idiopathic Nephrotic Syndrome.Not yet recruitingNCT07685093Not applicable
• Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular DiseasesRecruitingNCT07614477Phase 2
• SLIT ABS: Study on Patients With Autoimmune PodocytopathyRecruitingNCT07516964Not applicable
• A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental GlomerulosclerosisRecruitingNCT07499700Phase 2/3
• Obinutuzumab in Adult Rituximab-Dependent Nephrotic SyndromeNot yet recruitingNCT07233330Phase 2
• Short-term gluCOCOrticoid in Adult STEROID-sensitive Nephrotic Syndrome: The COCO-ASTEROID StudyNot yet recruitingNCT07151456Phase 4
• Epithelial Dysmetabolism and Renal Fibrosis in ANCA VasculitisRecruitingNCT07010250
• Non-invasive Diagnosis of Idiopathic Nephrotic SyndromesRecruitingNCT06820866
• Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics StudyNot yet recruitingNCT06792448
• An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte DiseasesRecruitingNCT06664814Phase 2
• A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change DiseaseRecruitingNCT06500702Phase 2
• Study of WAL0921 in Patients With Glomerular Kidney DiseasesRecruitingNCT06466135Phase 2
• Predictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1Not yet recruitingNCT06443034
• Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCDNot yet recruitingNCT06405100Phase 3
• Autoantibodies Against-nephrin in Idiopathic Nephrotic SyndromeRecruitingNCT06334692
• Circulating Factors in Nephrotic SyndromeNot yet recruitingNCT06315504
• National Registry of Rare Kidney DiseasesRecruitingNCT06065852
• Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change DiseaseRecruitingNCT05650619
• taVNS for FRNS in ChildrenRecruitingNCT05588063Not applicable
• A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)RecruitingNCT05583942Not applicable
• Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.RecruitingNCT05505500
• China Kidney Patient Trials NetworkRecruitingNCT05036850
• Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular DiseasesRecruitingNCT05003986Phase 2
• INS, B Cells and MicrobiotaRecruitingNCT04924712
• NEPTUNE Match StudyRecruitingNCT04571658Not applicable
• A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.RecruitingNCT04207580
• The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)RecruitingNCT03949972
• KOrea Renal Biobank NEtwoRk System TOward NExt-generation AnalysisRecruitingNCT03929887
• INSIGHT (Insight Into Nephrotic Syndrome)RecruitingNCT01605266
• Nephrotic Syndrome Study NetworkRecruitingNCT01209000
• UrApp for Childhood Nephrotic Syndrome Management (Incident Cohort)CompletedNCT04075656Not applicableResults posted
• Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change DiseaseCompletedNCT04009668Phase 2Results posted
• Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)CompletedNCT02592798Phase 2Results posted
• Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)CompletedNCT01129284Phase 4Results posted
• Tacrolimus Versus Prednisolone for the Treatment of Minimal Change DiseaseCompletedNCT00982072Phase 4Results posted
• Steroid Treatment for Kidney DiseaseCompletedNCT00065611Phase 3Results posted
• Immunophenotyping Profiling in Patients With Primary Nephrotic SyndromeCompletedNCT07702981
• REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE)Active, not recruitingNCT06635720Phase 3
• Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic SyndromeActive, not recruitingNCT05914155Phase 3
• Application of Hyperspectral Imaging in the Diagnosis of Glomerular DiseasesStatus unknownNCT05797051
• Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic SyndromeWithdrawnNCT05599815Phase 2
• Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS)TerminatedNCT05441826Phase 2
• Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With ProteinuriaCompletedNCT05314231Phase 1
• Rituximab for Idiopathic Nephrotic SyndromeCompletedNCT04494438Phase 3
• Global Kidney Patient Trials NetworkCompletedNCT04389827
• A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change DiseaseTerminatedNCT04387448Phase 2
• Rituximab for Refractory or Relapsed Focal Segmental Glomerulosclerosis or Minimal Change DiseaseCompletedNCT04369183
• A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)TerminatedNCT04235621
• Effect of Daily Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Proteinuria in Pediatric Patients With Idiopathic Nephrotic SyndromeCompletedNCT04169776Not applicable
• Reduce Immunosuppression With Atmp in NS ChildrEnCompletedNCT04034316Phase 2
• RItuximab From the FIRst Episode of Idiopathic Nephrotic SyndromeStatus unknownNCT03970577Phase 2
• CHILDNEPH The Canadian Childhood Nephrotic Syndrome StudyStatus unknownNCT03786263
• Diagnostic and Prognostic Value of Miss-1 Study in Children and Adult With Nephrotic Syndrome MISSNEPHROTIQUEStatus unknownNCT03592030
• Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic SyndromeStatus unknownNCT03298698Phase 3
• Active Vitamin D and Reduced Dose Prednisolone for Treatment in Minimal Change NephropathyCompletedNCT03210688Phase 4
• Diagnostic Value of Linked Color Imaging for Minimal Change Esophagitis in Nonerosive Reflux Esophagitis and GERDStatus unknownNCT03068572
• Valproic Acid for Idiopathic Nephrotic SyndromeStatus unknownNCT02896270Phase 2/3
• Efficiency of Levamisole for Maintaining Remission After the First Flare of Steroid Sensitive Nephrotic Syndrome in ChildrenCompletedNCT02818738Phase 3
• Adjusted Steroids Therapy in Childerens With Idiopathic Nephrotic SyndromeStatus unknownNCT02649413Phase 4
• Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis)Status unknownNCT02382874Phase 1
• Glucocorticoid in Treatment of Adult Idiopathic Nephrotic Syndrome：a Prospective Observational StudyCompletedNCT02298335Not applicable
• Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney FailureActive, not recruitingNCT02194582
• Vitamin D Supplementation in Glomerular DiseaseCompletedNCT01835639Not applicable
• A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic SyndromeCompletedNCT01763580Phase 4
• Factors of Steroid Dependency in Idiopathic Nephrotic SyndromeCompletedNCT01609426
• Study of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic SyndromeStatus unknownNCT01346007Phase 4
• Efficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During ChildhoodCompletedNCT01268033Phase 2/3
• Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic SyndromeCompletedNCT01197040Phase 3
• Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized StudyCompletedNCT01185197Phase 4
• Cyclophosphamide Versus Mycophenolate Mofetil for the Treatment of Steroid-dependent Nephrotic Syndrome in ChildrenCompletedNCT01092962Phase 3
• Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic SyndromeCompletedNCT01084980Phase 2/3
• Latent Viral Infection of Lymphoid Cells in Idiopathic Nephrotic SyndromeCompletedNCT00577525
• Kidney Disease BiomarkersCompletedNCT00255398

← Nephrosis, Lipoid overview